MAPT and Alzheimer disease: In summary, the expression of human tau on an amyloid background in 5xFADxhtau-KI mice alters transcriptional profiles of disease-associated pathways (mainly oxidative phosphorylation and mitochondrial function), which are found to be activated across post mortem brain regions of AD patients.